Kapola A, Musoke R, Manayon G, Fussi H, Bakari H, Ally H
Ann Glob Health. 2025; 91(1):4.
PMID: 39896105
PMC: 11784521.
DOI: 10.5334/aogh.4589.
Martin C, Muhwava L, Dada S, Scorgie F, Mullick S
AIDS Behav. 2025; .
PMID: 39779628
DOI: 10.1007/s10461-024-04596-5.
Admassu M, Nostlinger C, Hensen B
BMC Womens Health. 2024; 24(1):665.
PMID: 39725977
PMC: 11670510.
DOI: 10.1186/s12905-024-03516-y.
Baron D, Leslie H, Mabetha D, Becker N, Kahn K, Lippman S
Soc Sci Med. 2024; 361:117370.
PMID: 39366151
PMC: 11554290.
DOI: 10.1016/j.socscimed.2024.117370.
Shapley-Quinn M, Tenza S, Jensen D, Tauya T, Mampuru L, Etima J
AIDS Behav. 2024; 28(12):4209-4223.
PMID: 39343865
PMC: 11586305.
DOI: 10.1007/s10461-024-04503-y.
Formalized peer referral to HIV pre-exposure prophylaxis supported with self-testing: a mixed-methods pilot study among young Kenyan women.
McGowan M, Wairimu N, Reedy A, Mogere P, Culquichicon C, Njeru I
Front Public Health. 2024; 12:1428609.
PMID: 39324163
PMC: 11422135.
DOI: 10.3389/fpubh.2024.1428609.
We choose: Adolescent girls and young women's choice for an HIV prevention product in a cross-over randomized clinical trial conducted in South Africa, Uganda, and Zimbabwe.
Atujuna M, Williams K, Roberts S, Young A, Browne E, Mangxilana N
PLoS One. 2024; 19(8):e0308577.
PMID: 39208281
PMC: 11361692.
DOI: 10.1371/journal.pone.0308577.
"I was given PrEP, but had no privacy": Mystery shopper perspectives of PrEP counseling for adolescent girls and young women in Kisumu County, Kenya.
Vera M, Aketch H, Omom C, Otieno F, Owiti G, Sila J
PLoS One. 2024; 19(8):e0309075.
PMID: 39159171
PMC: 11332929.
DOI: 10.1371/journal.pone.0309075.
Evaluating Dual Process Decision-Making Along the PrEP Consumer Journey: New Insights for Supporting PrEP Use.
Lane B, Nguyen N, Fillmore H, Carnevale C, Sobieszczyk M, Zucker J
AIDS Behav. 2024; 28(9):2850-2862.
PMID: 38801501
PMC: 11390328.
DOI: 10.1007/s10461-024-04357-4.
Youth-friendly services was the magic: Experiences of adolescent girls and young women in the community PrEP study, South Africa.
Mudzingwa E, de Vos L, Fynn L, Atujuna M, Katz I, Hosek S
Glob Public Health. 2024; 19(1):2349918.
PMID: 38752416
PMC: 11101151.
DOI: 10.1080/17441692.2024.2349918.
Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa.
Rousseau E, Sikkema K, Julies R, Mazer K, OMalley G, Heffron R
J Int AIDS Soc. 2024; 27(5):e26254.
PMID: 38695101
PMC: 11063778.
DOI: 10.1002/jia2.26254.
High study participation but diverging adherence levels: qualitatively unpacking PrEP use among adolescent girls and young women over two years in Eastern Cape, South Africa.
Mudzingwa E, de Vos L, Atujuna M, Fynn L, Mugore M, Mabandla S
J Behav Med. 2023; 47(2):320-333.
PMID: 38081955
PMC: 10944421.
DOI: 10.1007/s10865-023-00462-2.
Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa.
Ndimande-Khoza M, Katz A, Moretlwe-Delany S, Travill D, Rousseau E, Omollo V
PLoS One. 2023; 18(11):e0292529.
PMID: 37963171
PMC: 10645326.
DOI: 10.1371/journal.pone.0292529.
Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa.
Khadka N, Gorbach P, Nyemba D, Mvududu R, Mashele N, Javanbakht M
Front Reprod Health. 2023; 5:1224474.
PMID: 37795521
PMC: 10546059.
DOI: 10.3389/frph.2023.1224474.
Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
de Vos L, Mudzingwa E, Fynn L, Atujuna M, Mugore M, Gandhi M
J Int AIDS Soc. 2023; 26(9):e26175.
PMID: 37758649
PMC: 10533377.
DOI: 10.1002/jia2.26175.
Changes in relationships, HIV risk, and feelings towards PrEP: findings from a qualitative explanatory study among participants in the CHARISMA intervention trial.
Hartmann M, Triplett N, Roberts S, Lanham M, Reddy K, Tenza S
BMC Womens Health. 2023; 23(1):440.
PMID: 37608373
PMC: 10464438.
DOI: 10.1186/s12905-023-02603-w.
The Importance of the Individual in PrEP Uptake: Multilevel Correlates of PrEP Uptake Among Adolescent Girls and Young Women in Tshwane, South Africa.
Bonner C, Minnis A, Ndirangu J, Browne F, Speizer I, Nyblade L
AIDS Behav. 2023; 27(12):4124-4130.
PMID: 37439915
DOI: 10.1007/s10461-023-04126-9.
Securing accelerated access to long-acting injectable cabotegravir for HIV prevention in low- and middle-income countries.
Jenkins S, Resar D, Panos Z, Staple A, Watkins M, Ripin D
J Int AIDS Soc. 2023; 26 Suppl 2:e26101.
PMID: 37439082
PMC: 10338995.
DOI: 10.1002/jia2.26101.
Adolescent Girls and Young Women's Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis.
Young A, Mancuso N, Atujuna M, Tenza S, Chitukuta M, Kemigisha D
AIDS Behav. 2023; 27(12):3941-3951.
PMID: 37392268
PMC: 10598125.
DOI: 10.1007/s10461-023-04109-w.
Barriers to Pre-Exposure Prophylaxis (PrEP) use for HIV: an integrative review.
Antonini M, Silva I, Elias H, Gerin L, Oliveira A, Reis R
Rev Bras Enferm. 2023; 76(3):e20210963.
PMID: 37377313
PMC: 10292616.
DOI: 10.1590/0034-7167-2021-0963.